Around the world, bacteria are becoming resistant to the antibiotics used to treat the infections they cause. Without urgent action, we are heading for a ‘post-antibiotic era’ in which common infections and minor injuries treatable for decades can once again kill and the benefits of advanced medical treatments will be lost.
Antibiotics are a precious resource that cannot be taken for granted.
The World Health Organisation (WHO) published a catalogue of 12 families of bacteria that pose the greatest threat to human health. They are antibiotic-resistant “priority pathogens”. By publishing this list the WHO aimed to guide and promote research and development of new antibiotics and antimicrobial treatments to address growing global resistance to antimicrobial medicines highlighting a number of gram-negative bacteria that are resistant to multiple antibiotics and built-in abilities to find new ways to resist treatment and can pass along genetic material that allows other bacteria to become drug-resistant as well.
SurgihoneyRO™ is the first published antimicrobial wound dressing tested against the WHO priority pathogens
- SurgihoneyRO™ has been shown to be effective against almost all these organisms
- The priority list includes four MDR bacterial strains commonly found in chronic wounds
- Treatment with SurgihoneyRO™ wound gel was shown to kill these MDR strains: carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, VRE and methicillin-resistant Staphlococcus aureus (MRSA)
- 11 of the 12 priority pathogens were eradicated or significantly reduced following application of SurgihoneyRO™ presenting a viable treatment option where MDR organisms are suspected or where the risk of MDR is high